Swarmer grants Justin Matthew Zeefe 6,428 stock options

The director’s options vest in full at the earlier of the grant’s one-year anniversary or the issuer’s 2027 Annual Meeting.

Rhea-AI Filing Summary

Swarmer, Inc. (SWMR) director Justin Matthew Zeefe received a grant of 6,428 stock options on October 1, 2026, covering 6,428 shares of common stock. The options have an exercise price of $16.38 per share and shall vest in full on the earlier of the one-year anniversary of the grant date and the issuer’s 2027 Annual Meeting. After the grant, his reported direct option position was 6,428 options.

Insider Trade Summary

Grant/Award: 6,428 shares

Grant/Award 1 txn

Insider Zeefe Justin Matthew

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1	6,428	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 6,428 contracts (Direct)

Footnotes (1)

1. F1. The shares underlying this option shall vest in full on the earlier of (i) the one-year anniversary of the grant date and (ii) the Issuer's 2027 Annual Meeting.

Key Figures

Stock options granted: 6,428 options Exercise price: $16.38 per share Reported direct option position after grant: 6,428 options +2 more

5 metrics

Stock options granted 6,428 options Grant on October 1, 2026

Exercise price $16.38 per share Stock options granted to Justin Matthew Zeefe

Reported direct option position after grant 6,428 options After the October 1, 2026 grant

Vesting Earlier of the one-year anniversary of the grant date or the 2027 Annual Meeting Options vest in full

Expiration date October 1, 2036 Stock options

Key Terms

Stock Option (right to buy), exercise price, vest in full

3 terms

Stock Option (right to buy) financial

"Stock Option (right to buy)"

exercise price financial

"exercise price of $16.38 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in full financial

"shall vest in full on the earlier of"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many stock options did SWMR director Justin Matthew Zeefe receive?

Justin Matthew Zeefe received 6,428 stock options on October 1, 2026, covering 6,428 shares of common stock. The exercise price is $16.38 per share.

When do Justin Matthew Zeefe’s SWMR stock options expire?

The options expire on October 1, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 05:48 PM Accepted by SEC EDGAR 10/02/2026 - 05:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zeefe Justin Matthew

(Last) (First) (Middle)

C/O SWARMER, INC

4515 SETON CENTER PKWY #330

(Street)

AUSTIN TEXAS 78759

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Swarmer, Inc [ SWMR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$16.38	10/01/2026		A		6,428		(1)	10/01/2036	Common Stock	6,428	$0	6,428	D

Explanation of Responses:

1. The shares underlying this option shall vest in full on the earlier of (i) the one-year anniversary of the grant date and (ii) the Issuer's 2027 Annual Meeting.

	/s/ Kostantinos Skordalos, Attorney-in-Fact for Justin Zeefe	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)